documents: FDA-2017-N-6373-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-N-6373-0001 FDA FDA-2017-N-6373 Roxane Laboratories, Inc.; Withdrawal of Approval of a New Drug Application for ROXICODONE (Oxycodone Hydrochloride) Sustained-Release Tablets, 10 Milligrams and 30 Milligrams Notice Withdrawal 2017-11-29T05:00:00Z 2017 11 2017-11-29T05:00:00Z   2017-11-29T16:30:15Z 2017-25771 0 0 0900006482cbbc78

Links from other tables